Home › Funds › GOLDENTREE ASSET MANAGEMENT LP › JAZZ
GOLDENTREE ASSET MANAGEMENT LP position in JAZZ
JAZZ PHARMACEUTICALS PLC · Health Care
GOLDENTREE ASSET MANAGEMENT LP reported holding 421,943 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$97.5M, representing 5.11% of its reported portfolio and ranking #4 among its reported holdings. GOLDENTREE ASSET MANAGEMENT LP has disclosed JAZZ holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How GOLDENTREE ASSET MANAGEMENT LP's JAZZ position evolved
GOLDENTREE ASSET MANAGEMENT LP first disclosed a stake in JAZZ in Q3 2025 at 1,137,106 shares (US$149.6M). Across 5 filings, GOLDENTREE ASSET MANAGEMENT LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 421,943 shares valued at US$97.5M — an increase of 127,508 shares quarter over quarter.. Notable position changes include a 63% trim in Q4 2025 (shares rose 11% over the following quarter), a 38% trim in Q2 2026 (shares fell 4% over the following quarter), a 43% increase in Q3 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.14M | $149.60M | New |
| Q4 2025 | 420.34K | $71.34M | Reduce |
| Q1 2026 | 475.55K | $89.76M | Add |
| Q2 2026 | 294.44K | $70.84M | Reduce |
| Q3 2026 | 421.94K | $97.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 40 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), Boston Trust Walden Corp (US$98.3M), Sofinnova Investments, Inc. (US$97.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.40M sh · $323.77M · Q3 2026
- Boston Trust Walden Corp 424.57K sh · $98.30M · Q3 2026
- Sofinnova Investments, Inc. 422.38K sh · $97.79M · Q3 2026
More on GOLDENTREE ASSET MANAGEMENT LP
FAQ
How long has GOLDENTREE ASSET MANAGEMENT LP held JAZZ?
GOLDENTREE ASSET MANAGEMENT LP has disclosed JAZZ holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is GOLDENTREE ASSET MANAGEMENT LP's current position in JAZZ?
As of Q3 2026, GOLDENTREE ASSET MANAGEMENT LP holds 421.94K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $97.55M, representing 5.11% of its reported portfolio and ranking #4.
Has GOLDENTREE ASSET MANAGEMENT LP been buying or selling JAZZ?
In the latest 13F filing (Q3 2026), GOLDENTREE ASSET MANAGEMENT LP increased its position in JAZZ.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., Boston Trust Walden Corp, Sofinnova Investments, Inc., among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.